Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-13

Clinical Trial Update: Dexmedetomidine on Tourniquet Induced -Systemic Effects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine for tourniquet-induced systemic effects in procedures involving arthropathy of the knee and spinal anesthesia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Wonkwang University Hospital | Conditions: Arthropathy of Knee, Spinal Anesthesia | Phase 4 | Status: COMPLETED